Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00541_DB01026_nanopub.RAAxRloFl5FwMPpMdtdDnhdh2rs8Ik5RfBoDl9GwMErMM#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00541_DB01026 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00541_DB01026 label "DDI between Vincristine and Ketoconazole - Ketoconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Ketoconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00541_DB01026]" assertion.
- drugbank_resource:DB00541_DB01026 identifier "drugbank_resource:DB00541_DB01026" assertion.
- drugbank_resource:DB00541_DB01026 title "DDI between Vincristine and Ketoconazole - Ketoconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Ketoconazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB01026 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00541_DB01026 assertion.
- drugbank:DB00541 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00541_DB01026 assertion.